×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Yahoo Finance
(Nasdaq: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for...
1 month ago
Cash-strapped Salarius lays off over 50% of staff, mulls options
Fierce Biotech
Despite a string of recent good news on the clinical front, Salarius Pharmaceuticals is halving its workforce and bracing for the potential...
9 months ago
Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
markets.businessinsider.com
Shares of Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) rose sharply in today's pre-market trading following fourth-quarter results. Salari.
1 month ago
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Short Interest Update
Defense World
Read Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Short Interest Update at Defense World.
5 days ago
Salarius presents SP-3164 targeted protein degrader preclinical data - TipRanks.com
Tipranks
Salarius Pharmaceuticals announces the presentation of a poster related to the company's novel molecular glue, SP-3164, at the European Hematology...
1 day ago
Salarius: Q1 Earnings Snapshot | Region | jacksonvilleprogress.com
Jacksonville Daily Progress
HOUSTON (AP) — HOUSTON (AP) — Salarius Pharmaceuticals, Inc. (SLRX) on Monday reported a loss of $1.7 million in its first quarter.
2 days ago
Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders
Yahoo Finance
Expands IP portfolio with composition-of-matter protection into 2039 for novel molecular glues Protein degrader portfolio now includes 17...
4 months ago
Salarius Pharmaceuticals cuts half of workforce despite positive clinical developments
The Business Journals
In 2019, Salarius and struggling Boston-based pharmaceutical company Flex Pharma went through a reverse merger, making Salarius a public company...
9 months ago
Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday
markets.businessinsider.com
Wall Street expects Dada Nexus Limited (NASDAQ:DADA) to report quarterly earnings at 9 cents per share on revenue of $432.74 million after the...
1 month ago
Salarius receives FDA clearance for IND application of SP-3164 Phase 1 trial - TipRanks.com
Tipranks
Salarius Pharmaceuticals announces U.S. Food and Drug Administration, FDA, clearance of the company's investigational new drug, IND application to commence...
1 day ago